The University of Chicago Header Logo

Connection

Peter H. O'Donnell to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications Peter H. O'Donnell has written about Maximum Tolerated Dose.
Peter H. O'Donnell
Connection Strength
0.120
Maximum Tolerated Dose
  1. A phase I study of continuous infusion cilengitide in patients with solid tumors. Invest New Drugs. 2012 Apr; 30(2):604-10.
    View in: PubMed
    Score: 0.085
  2. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017 11; 18(11):1483-1492.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.